1. Home
  2. XOMAO vs GRABW Comparison

XOMAO vs GRABW Comparison

Compare XOMAO & GRABW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XOMAO
  • GRABW
  • Stock Information
  • Founded
  • XOMAO N/A
  • GRABW 2012
  • Country
  • XOMAO United States
  • GRABW Singapore
  • Employees
  • XOMAO 13
  • GRABW 11267
  • Industry
  • XOMAO Biotechnology: Pharmaceutical Preparations
  • GRABW Business Services
  • Sector
  • XOMAO Health Care
  • GRABW Consumer Discretionary
  • Exchange
  • XOMAO Nasdaq
  • GRABW Nasdaq
  • Market Cap
  • XOMAO N/A
  • GRABW N/A
  • IPO Year
  • XOMAO N/A
  • GRABW N/A
  • Fundamental
  • Price
  • XOMAO $25.25
  • GRABW $0.39
  • Analyst Decision
  • XOMAO
  • GRABW
  • Analyst Count
  • XOMAO 0
  • GRABW 0
  • Target Price
  • XOMAO N/A
  • GRABW N/A
  • AVG Volume (30 Days)
  • XOMAO N/A
  • GRABW 54.7K
  • Earning Date
  • XOMAO N/A
  • GRABW 02-21-2025
  • Dividend Yield
  • XOMAO N/A
  • GRABW N/A
  • EPS Growth
  • XOMAO N/A
  • GRABW N/A
  • EPS
  • XOMAO N/A
  • GRABW N/A
  • Revenue
  • XOMAO N/A
  • GRABW $2,686,000,000.00
  • Revenue This Year
  • XOMAO N/A
  • GRABW N/A
  • Revenue Next Year
  • XOMAO N/A
  • GRABW N/A
  • P/E Ratio
  • XOMAO N/A
  • GRABW N/A
  • Revenue Growth
  • XOMAO N/A
  • GRABW 21.65
  • 52 Week Low
  • XOMAO N/A
  • GRABW $0.15
  • 52 Week High
  • XOMAO N/A
  • GRABW $0.59
  • Technical
  • Relative Strength Index (RSI)
  • XOMAO 52.57
  • GRABW 42.80
  • Support Level
  • XOMAO $25.10
  • GRABW $0.40
  • Resistance Level
  • XOMAO $25.30
  • GRABW $0.45
  • Average True Range (ATR)
  • XOMAO 0.11
  • GRABW 0.05
  • MACD
  • XOMAO 0.03
  • GRABW -0.01
  • Stochastic Oscillator
  • XOMAO 71.45
  • GRABW 0.00

About XOMAO AGNC Investment Corp.

XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.

About GRABW Grab Holdings Limited Warrant

Founded in 2012, Grab provides ride-sharing services, food and grocery delivery, and financial services (payments, consumer loans, and enterprise offerings) in eight Southeast-Asian countries through its mobile platform. The company partners with merchants and riders, connecting them with consumers while charging commission to both sides. Grab has a leading market share in and derives 89% of its revenue from its core businesses, ride-sharing and food delivery. Singapore and Malaysia contributed 58% of revenue as of end-2021. Grab's main competitors in Southeast Asia are Foodpanda and Gojek, the ride-sharing arm of GoTo. Its financial services business is still in its nascent stage and provides minimal revenue currently. The company now also generates advertising revenue.

Share on Social Networks: